Prognostic Factors Affecting Survival of Gastric GIST

NCT04269941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2020-02-17

No results posted yet for this study

Summary

Gastrointestinal stromal tumor (GIST) is the most common non-epithelial mesenchymal tumor of the gastrointestinal tract. Surgical treatment is the only curative therapy for primary localized GIST. This study aimed to identify the clinicopathological characteristics of gastric GISTs and to study the predictive factors for recurrence in Tunisian patients.

Conditions

  • Gastric GIST

Interventions

OTHER

total or subtotal gastrectomy

resection of the gastric tumor

Sponsors & Collaborators

  • Université de Sousse

    lead OTHER

Principal Investigators

  • ALI BEN ALI, PROFESSOR · university of sousse

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2015-01-29
Completion
2018-01-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04269941 on ClinicalTrials.gov